Drug Approval | August 25, 2024
BI Sky Global successfully completes FDA MoCRA registration
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and older
USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
The brand will establish an integrated hearing care ecosystem at Neuberg Diagnostics centers across the length and breadth of the country
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
AGEasy has made significant strides in addressing the pressing health concerns of seniors in India
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
Subscribe To Our Newsletter & Stay Updated
